-
公开(公告)号:US07652057B2
公开(公告)日:2010-01-26
申请号:US11511542
申请日:2006-08-29
IPC分类号: A61K31/4152 , C07D231/08
CPC分类号: C07D231/20 , C07D231/22 , C07D231/26 , C07D231/54 , C07D231/56 , C07D471/04 , C07D487/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式的化合物及其药学上可接受的盐和酯,其中R 1至R 4具有权利要求1中给出的含义,可以以药物组合物的形式使用。
-
公开(公告)号:US07547697B2
公开(公告)日:2009-06-16
申请号:US11824971
申请日:2007-07-02
IPC分类号: A61K31/502 , A61K31/504 , A61K31/5025 , A61K31/50 , C07D237/08 , C07D237/14 , C07D237/16 , C07D237/28 , C07D491/08 , A61P3/10 , A61P3/04 , A61P3/06 , A61P9/12 , C07D307/12 , C07C49/105 , C07C49/11 , C07C49/115 , C07C49/12 , C07C49/15
CPC分类号: C07D237/08
摘要: Compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof for use as pharmaceutical compositions.
摘要翻译: 式(I)化合物:及其药学上可接受的盐和酯,用作药物组合物。
-
3.
公开(公告)号:US08129423B2
公开(公告)日:2012-03-06
申请号:US11871318
申请日:2007-10-12
申请人: Jean Ackermann , Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander V. Mayweg , Werner Neidhart , Tadakatsu Takahashi
发明人: Jean Ackermann , Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander V. Mayweg , Werner Neidhart , Tadakatsu Takahashi
IPC分类号: A61K31/4152 , A61K31/4166 , C07D233/02
CPC分类号: C07D233/02 , A61K9/2054 , A61K9/4866 , C07D233/06 , C07D233/10 , C07D233/28 , C07D471/06 , C07D471/10
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式的化合物及其药学上可接受的盐和酯,其中R 1至R 6具有权利要求1中给出的含义,可以以药物组合物的形式使用。
-
公开(公告)号:US07678795B2
公开(公告)日:2010-03-16
申请号:US11481330
申请日:2006-07-05
IPC分类号: C07D237/36 , C07D237/28 , A61K31/502
CPC分类号: C07D403/04 , C07D237/08 , C07D237/26 , C07D237/28 , C07D417/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式的化合物及其药学上可接受的盐和酯,其中R 1至R 4具有权利要求1中给出的含义,可以以药物组合物的形式使用。
-
公开(公告)号:US20080009499A1
公开(公告)日:2008-01-10
申请号:US11824971
申请日:2007-07-02
IPC分类号: A61K31/502 , A61P5/00 , C07D237/26
CPC分类号: C07D237/08
摘要: Compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof for use as pharmaceutical compositions.
摘要翻译: 式(I)化合物:及其药学上可接受的盐和酯,用作药物组合物。
-
公开(公告)号:US20090275573A1
公开(公告)日:2009-11-05
申请号:US12424587
申请日:2009-04-16
IPC分类号: A61K31/5365 , C07D487/04 , A61K31/4188 , A61K31/437 , C07D471/04 , C07D498/04
CPC分类号: C07D487/04 , C07D471/04 , C07D498/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein A and R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式及其药学上可接受的盐和酯的化合物,其中A和R 1至R 4具有权利要求1中给出的含义,可以以药物组合物的形式使用。
-
公开(公告)号:US08501940B2
公开(公告)日:2013-08-06
申请号:US12491278
申请日:2009-06-25
IPC分类号: C07D237/36 , A01N43/58
CPC分类号: C07D237/28 , C07D403/04
摘要: Provided herein are compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof, which are useful as pharmaceutical compositions for the treatment of metabolic diseases and disorders.
摘要翻译: 本文提供了式(I)化合物:及其药学上可接受的盐和酯,其可用作治疗代谢疾病和病症的药物组合物。
-
公开(公告)号:US08124636B2
公开(公告)日:2012-02-28
申请号:US12424587
申请日:2009-04-16
IPC分类号: A61K31/4184 , C07D235/02
CPC分类号: C07D487/04 , C07D471/04 , C07D498/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein A and R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式及其药学上可接受的盐和酯的化合物,其中A和R 1至R 4具有权利要求1中给出的含义,可以以药物组合物的形式使用。
-
公开(公告)号:US20100016325A1
公开(公告)日:2010-01-21
申请号:US12491278
申请日:2009-06-25
IPC分类号: A61K31/502 , C07D237/28 , A61P3/10 , A61P3/04
CPC分类号: C07D237/28 , C07D403/04
摘要: Provided herein are compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof, which are useful as pharmaceutical compositions for the treatment of metabolic diseases and disorders.
摘要翻译: 本文提供了式(I)化合物:及其药学上可接受的盐和酯,其可用作治疗代谢疾病和病症的药物组合物。
-
10.
公开(公告)号:US08211913B2
公开(公告)日:2012-07-03
申请号:US12372244
申请日:2009-02-17
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: C07D213/02 , A61K31/44
CPC分类号: C07D213/76
摘要: Compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof used in the form of pharmaceutical compositions.
摘要翻译: 式(I)化合物及其药学上可接受的盐和酯以药物组合物的形式使用。
-
-
-
-
-
-
-
-
-